Robot-assisted Training
Evaluation of a Portable Isokinetic Knee Training Device for Quadriceps Rehabilitation in Children With SMA
1 other identifier
interventional
13
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the long-term effects of isokinetic rehabilitation training in patients with spinal muscular atrophy (SMA). The main question it aims to answer is:
- Does isokinetic training at fixed angular velocity improve muscle strength and functional recovery in SMA patients? Participants will:
- Perform isokinetic training using a portable device with a fixed angular velocity.
- Undergo long-term rehabilitation sessions, with assessments of muscle strength and overall functional improvement over the training period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedStudy Start
First participant enrolled
February 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedAugust 29, 2025
August 1, 2025
6 months
October 3, 2024
August 27, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Change in cross sectional area of quadriceps
Using Magnetic Resonance Imaging (MRI)
Baseline, after 1.5 months, after 3 months and after 4 months
Change in longitudinal cross-sectional width of quadriceps
Using Magnetic Resonance Imaging (MRI)
Baseline, after 1.5 months, after 3 months and after 4 months
Change in peak torque
Using isokinetic training robot to measure.
Baseline, after 1.5 months, after 3 months and after 4 months
Change in average torque
Using isokinetic training robot to measure.
Baseline, after 1.5 months, after 3 months and after 4 months
Change in work of knee
Work = Torque \* Speed
Baseline, after 1.5 months, after 3 months and after 4 months
Change in Surface Electromyography (sEMG)
Baseline, after 1.5 months, after 3 months and after 4 months
Change in Nerve conduction
Nerve Conduction Velocity Testing System
Baseline, after 1.5 months, after 3 months and after 4 months
Secondary Outcomes (3)
Change in weight
Baseline, after 1.5 months, after 3 months and after 4 months
Change in height
Baseline, after 1.5 months, after 3 months and after 4 months
Change in joint angle
Baseline, after 1.5 months, after 3 months and after 4 months
Study Arms (3)
Robot-assisted Rehabilitation for children with SMA type II
EXPERIMENTALNon-robot-assisted Rehabilitation for children with SMA type II
NO INTERVENTIONPrior to the intervention, all participants will complete a 1.5-month "Stage 0" observation period with no robot assistance. During this time, we will record each child's sit-to-stand angle to establish baseline (control) measurements.
Biomechanical measures for healthy children
NO INTERVENTIONA single set of biomechanical measurements will be taken from healthy children to serve as a reference baseline.
Interventions
A child with SMA will use a wearable isokinetic training robot to train the knee joint for three stages. ( Stage 1: 1.5 months=30 sessions; Stage 2 (follow up): 1.5 months=18 sessions, Stage 3(follow up) = 0 session)
Eligibility Criteria
You may qualify if:
- Age range: 6-12 years old.
- Diagnosed with Type II Spinal Muscular Atrophy (SMA).
You may not qualify if:
- Participants with severe comorbidities, implanted medical devices preventing MRI or claustrophobia were excluded from the study.
- Refusal to provide informed consent or inability to complete the entire study protocol, among other factors;
- Uncontrolled hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥95 mmHg) or congestive heart failure classified as New York Heart Association (NYHA) Class III or IV;
- Cognitively impaired or unable to comprehend the requirements of study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking University Third Hospitallead
- Beihang Universitycollaborator
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100091, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- 7 Children with SMA, 6 Healthy Children as comparison
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 3, 2024
First Posted
October 18, 2024
Study Start
February 25, 2025
Primary Completion
August 30, 2025
Study Completion
August 30, 2025
Last Updated
August 29, 2025
Record last verified: 2025-08